Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Compromised kidney functions among the aged].
Yorioka N. Yorioka N. Nihon Naika Gakkai Zasshi. 2001 Jul 10;90(7):1207-13. Nihon Naika Gakkai Zasshi. 2001. PMID: 11519096 Japanese. No abstract available.
[Hyperlipidemia and renal disease].
Yorioka N. Yorioka N. Nihon Rinsho. 2001 Feb;59 Suppl 2:716-9. Nihon Rinsho. 2001. PMID: 11351678 Review. Japanese. No abstract available.
Vascular calcification in chronic kidney disease.
Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N; Vascular Calcification Work Group. Goodman WG, et al. Among authors: yorioka n. Am J Kidney Dis. 2004 Mar;43(3):572-9. doi: 10.1053/j.ajkd.2003.12.005. Am J Kidney Dis. 2004. PMID: 14981617 Review. No abstract available.
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators. Torres VE, et al. N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.
Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial.
Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Shuto H, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y; Refractory Nephrotic Syndrome Study Group. Saito T, et al. Among authors: yorioka n. Clin Exp Nephrol. 2014 Oct;18(5):784-94. doi: 10.1007/s10157-013-0925-2. Epub 2013 Dec 23. Clin Exp Nephrol. 2014. PMID: 24363128 Free PMC article. Clinical Trial.
[Guidelines for the management of refractory nephrotic syndrome--from investigations between 1997 and 2001--research project team for progressive renal lesions in the Ministry of Health, Labor and Welfare, Japan].
Sakai H, Kurokawa K, Saito T, Shiiki H, Nishi S, Mitarai T, Yokoyama H, Yoshimura A, Yorioka N. Sakai H, et al. Among authors: yorioka n. Nihon Jinzo Gakkai Shi. 2002 Dec;44(8):751-61. Nihon Jinzo Gakkai Shi. 2002. PMID: 12607964 Review. Japanese. No abstract available.
A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).
Shibasaki T, Koyama A, Hishida A, Muso E, Osawa G, Yamabe H, Shiiki H, Makino H, Sato H, Ishikawa I, Maeda K, Tomita K, Arakawa M, Ishida M, Sato M, Nagase M, Kashihara N, Yorioka N, Koike T, Saito T, Harada T, Mitarai T, Sugisaki T, Nagasawa T, Tomino Y, Nojima Y, Kobayashi Y, Sakai O. Shibasaki T, et al. Among authors: yorioka n. Clin Exp Nephrol. 2004 Jun;8(2):117-26. doi: 10.1007/s10157-004-0276-0. Clin Exp Nephrol. 2004. PMID: 15235928 Clinical Trial.
Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activity.
Matsuda T, Kaji K, Nishimura N, Asada S, Koizumi A, Tanaka M, Yorioka N, Tsuji Y, Kitagawa K, Sato S, Namisaki T, Akahane T, Yoshiji H. Matsuda T, et al. Among authors: yorioka n. Heliyon. 2024 Sep 27;10(19):e38647. doi: 10.1016/j.heliyon.2024.e38647. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39398008 Free PMC article.
222 results